Abstract 357: Pan-HER, an antibody mixture simultaneously targeting EGFR, HER2, and HER3, is highly effective in triple negative breast cancer patient-derived xenografts

Author(s):  
Roberto R. Rosato ◽  
Don S. Choi ◽  
Wei Qian ◽  
Wen Chen ◽  
Johan Lantto ◽  
...  
BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Margarite D. Matossian ◽  
Hope E. Burks ◽  
Steven Elliott ◽  
Van T. Hoang ◽  
Annie C. Bowles ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document